These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 24947090)

  • 41. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
    Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
    Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Primary plasma cell leukemia: what role does flow cytometry play?].
    Louati N; Fakhfakh Y; Chaari M; Rekik T; Kassar O; Elloumi M; Mnif H
    Ann Biol Clin (Paris); 2022 Sep; 80(5):471-477. PubMed ID: 36453736
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Review of phenotypic markers used in flow cytometric analysis of MGUS and MM, and applicability of flow cytometry in other plasma cell disorders.
    Raja KR; Kovarova L; Hajek R
    Br J Haematol; 2010 May; 149(3):334-51. PubMed ID: 20201947
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The immunophenotypic characteristics of 260 patients with CD5 + B cell lymphoproliferative disorders].
    Yi S; Li Z; Wang H; Liu W; Lyu R; Yu Z; Qi J; Qiu L
    Zhonghua Xue Ye Xue Za Zhi; 2014 Apr; 35(4):337-41. PubMed ID: 24759024
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Flow cytometric immunophenotyping of adult T-cell leukemia/lymphoma using CD3 gating.
    Yokote T; Akioka T; Oka S; Hara S; Kobayashi K; Nakajima H; Yamano T; Ikemoto T; Shimizu A; Tsuji M; Hanafusa T
    Am J Clin Pathol; 2005 Aug; 124(2):199-204. PubMed ID: 16040289
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Clinical and evolutive study of plasma cell leukemia. Apropos of 9 cases].
    Panizo Santos C; Cuesta Palomero B; Calasanz Abinzano MJ; Rifón Roca J; Rocha Hernando E
    Rev Clin Esp; 1997 May; 197(5):341-5. PubMed ID: 9280968
    [TBL] [Abstract][Full Text] [Related]  

  • 47. CD38 - Negative Anaplastic Plasma Cell Myeloma: A Rare Case Report.
    Thi Vinh Do A; Lan Anh L
    Cureus; 2022 Jan; 14(1):e20909. PubMed ID: 35004078
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunophenotypic differentiation between neoplastic plasma cells in mature B-cell lymphoma vs plasma cell myeloma.
    Seegmiller AC; Xu Y; McKenna RW; Karandikar NJ
    Am J Clin Pathol; 2007 Feb; 127(2):176-81. PubMed ID: 17210522
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunophenotypic characteristics of T-acute lymphoblastic leukemia cells in relation to DPP IV enzyme expression.
    Klobusická M; Babusíková O
    Neoplasma; 1998; 45(4):237-42. PubMed ID: 9890667
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Aggressive primary plasma cell leukemia with skin manifestations, trisomy 8 and molecular oligoclonal features.
    Robak T; Urbańska-Rys H; Robak E; Bartkowiak J; Strzelecka B; Biernat W; Kordek R
    Leuk Lymphoma; 2002 May; 43(5):1067-73. PubMed ID: 12148888
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Diagnostic Value of CD27 Antigen in Patients with Multiple Myeloma].
    Wang H; Liu L; Liu F; Chen LJ; Qu XY; Li JY; Wu YJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Aug; 25(4):1069-1073. PubMed ID: 28823270
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical and Laboratory Characteristics of IgM Primary Plasma Cell Leukemia.
    Wu Y; Zhang X; Ma X; Suo X; Li R
    Clin Lab; 2023 Jul; 69(7):. PubMed ID: 37436385
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunophenotypic heterogeneity of normal plasma cells: comparison with minimal residual plasma cell myeloma.
    Liu D; Lin P; Hu Y; Zhou Y; Tang G; Powers L; Medeiros LJ; Jorgensen JL; Wang SA
    J Clin Pathol; 2012 Sep; 65(9):823-9. PubMed ID: 22685235
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Acute promyelocytic leukemia: four distinct patterns by flow cytometry immunophenotyping.
    Gorczyca W
    Pol J Pathol; 2012 Mar; 63(1):8-17. PubMed ID: 22535601
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Two cases of plasma cell leukemia with atypical immunophenotype.
    Buda G; Carulli G; Orciuolo E; Cannizzo E; Zucca A; Azzarà A; Rossi A; Galimberti S; Cecconi N; Petrini M
    Acta Haematol; 2007; 118(1):27-9. PubMed ID: 17429194
    [No Abstract]   [Full Text] [Related]  

  • 56. CD56 expression of neuroendocrine neoplasms on immunophenotyping by flow cytometry: a novel diagnostic approach to fine-needle aspiration biopsy.
    Farinola MA; Weir EG; Ali SZ
    Cancer; 2003 Aug; 99(4):240-6. PubMed ID: 12925986
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CD5-negative, CD10-negative small B-cell leukemia: variant of chronic lymphocytic leukemia or a distinct entity?
    Sheikh SS; Kallakury BV; Al-Kuraya KA; Meck J; Hartmann DP; Bagg A
    Am J Hematol; 2002 Dec; 71(4):306-10. PubMed ID: 12447961
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Flow cytometric features of angioimmunoblastic T-cell lymphoma.
    Chen W; Kesler MV; Karandikar NJ; McKenna RW; Kroft SH
    Cytometry B Clin Cytom; 2006 May; 70(3):142-8. PubMed ID: 16572417
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Multiparameter immunophenotyping by flow cytometry as a diagnostic tool in multiple myeloma and monoclonal gammopathy of undetermined significance.
    Carulli G; Ottaviano V; Cannizzo E; Giuntini S; Manetti C; Ciancia EM; Azzarà A
    Clin Ter; 2012; 163(5):387-92. PubMed ID: 23099966
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Flow cytometric immunophenotyping of plasma cells across the spectrum of plasma cell proliferative disorders: A fresh insight with pattern-based recognition.
    Das N; Dahiya M; Gupta R; Rai S; Singh S; Prajapati VK; Kumar L; Sharma A; Sahoo RK; Gogia A
    Cytometry B Clin Cytom; 2022 Jul; 102(4):292-302. PubMed ID: 35212134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.